Potential of mezlocillin as empiric single-agent therapy in febrile granulocytopenic cancer patients.

Mezlocillin was used as an initial empiric antibiotic therapy for febrile (> 101 degrees F, ca. 38.33 degrees C) granulocytopenic (< 1,000/microliter) cancer patients. Patients known to be colonized with an organism resistant to 100 micrograms of mezlocillin per mol were excluded. The initial 25 cas...

Descrición completa

Detalles Bibliográficos

Publicado en:	Antimicrob Agents Chemother
Principais autores:	Wade, J C, Schimpff, S C, Newman, K A, Fortner, C L, Moody, M R, Young, V M, Wiernik, P H
Formato:	Artigo
Idioma:	Inglês
Publicado:	American Society for Microbiology (ASM) 1980
Assuntos:	Research Article
Acceso en liña:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC283987/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6449902/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.18.2.299
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!